XML 32 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Plans (Details) (USD $)
3 Months Ended 6 Months Ended
Jul. 28, 2012
Y
Apr. 28, 2012
Y
Jul. 30, 2011
Jul. 28, 2012
Y
Jul. 30, 2011
Jan. 28, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Expense $ 6,600,000   $ 6,700,000 $ 14,700,000 $ 13,500,000  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]            
Weighted-average fair value of stock options granted $ 13.48   $ 14.14 $ 14.23 $ 14.53  
Risk-free interest rate 0.50%   1.70% 0.60% 1.80%  
Expected life (years) 4.2   4.2 4.2 4.2  
Expected volatility 43.40%   41.30% 41.00% 41.70%  
Expected annual forfeiture rate 3.00%   1.50% 3.00% 1.50%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]            
Outstanding stock options 3,165,573 3,676,423   3,676,423    
Options, Grants in Period, Net of Forfeitures 48,750 902,000        
Options, Exercises in Period (43,387) (1,345,525)        
Options, Forfeitures and Expirations in Period (37,500) (67,325)        
Outstanding stock options 3,133,436 3,165,573   3,133,436    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Options, Vested and Expected to Vest, Outstanding, Number 2,956,160     2,956,160    
Options, Exercisable, Number 1,063,497     1,063,497    
Options, Outstanding, Weighted Average Exercise Price $ 34.69 $ 34.46   $ 34.69   $ 28.36
Options, Grants in Period, Weighted Average Exercise Price $ 37.59 $ 43.87   $ 37.59    
Options, Exercises in Period, Weighted Average Exercise Price $ 17.24 $ 23.97   $ 17.24    
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 39.00 $ 37.06        
Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 34.51     $ 34.51    
Options, Exercisable, Weighted Average Exercise Price $ 26.50     $ 26.50    
Options, Outstanding, Weighted Average Remaining Contractual Term 5.0 5.2   5.0    
Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 5.0          
Options, Exercisable, Weighted Average Remaining Contractual Term 3.6          
Options, Outstanding, Intrinsic Value 22,437,000 17,625,000   22,437,000    
Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 21,680,000     21,680,000    
Options, Exercisable, Intrinsic Value 15,461,000     15,461,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]            
Total intrinsic value of stock options exercised 953,000   2,378,000 29,075,000 5,545,000  
Total fair value of restricted stock vested 804,000   721,000 21,907,000 11,618,000  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized 45,300,000     45,300,000    
Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 1.9          
Stock Options [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period       4 years    
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date       7 years    
Restricted Stock [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period       5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period       3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Nonvested, beginning balance 805,889 741,289   741,289    
Grants in Period 41,859 525,800        
Vested in Period (22,864) (454,800)        
Forfeited in Period (3,000) (6,400)        
Nonvested, ending balance 821,884 805,889   821,884    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]            
Nonvested, Weighted Average Grant Date Fair Value $ 42.63 $ 42.65   $ 42.63   $ 39.40
Grants in Period, Weighted Average Grant Date Fair Value $ 37.08 $ 43.85        
Vested in Period, Weighted Average Grant Date Fair Value $ 33.24 $ 38.79        
Forfeited in Period, Weighted Average Grant Date Fair Value $ 42.03 $ 39.97   $ 42.03    
Nonemployee Board of Directors [Member] | Restricted Stock [Member]
           
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Vested in Period (22,864)          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]            
Deferred Compensation Arrangement, Fair Value of Shares Issued to Each Director $ 95,000